DIMERISIERTES PEPTID

Patent europeic · EP1584627 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP1584627
Numer da la dumonda
EP04702444
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
15-01-2004
Publitgà
12-10-2005
Concedì
07-10-2009
Stritgà
15-01-2024
Motiv
Durada maximala cuntanschida
Classas IPC
C07K 7/06 (2006.01)
C07K 7/08 (2006.01)
C07K 14/82 (2006.01)
A61K 39/00 (2006.01)
A61P 35/00 (2006.01)
A61P 37/04 (2006.01)
C07K 14/705 (2006.01)
Prioritad
JP 2003007122 15.01.2003
Dumonda PCT
PCT/JP2004/000254 15.01.2004
Publicaziun PCT
WO2004/063217 29.07.2004
Lingua da l’annunzia
giapunais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 15-01-2024

    Durada maximala cuntanschida

    Published in Swissreg on 15.01.2024

  2. 01-02-2023

    Midada

    Published in Swissreg on 01.02.2023

  3. 08-06-2022

    Adressa midada

    Owner
    International Institute of Cancer Immunology, Inc., 13-9, Enoki-cho, Suita-shi, Osaka-fu, Japan, Sumitomo Dainippon Pharma Co., Ltd., 6-8, Dosho-machi 2-chome, Chuo-ku, Osaka-shi, Osaka 541-8524, Japan → International Institute of Cancer Immunology, Inc., 13-9, Enoki-cho, Suita-shi, Osaka-fu, Japan, Sumitomo Pharma Co., Ltd., 6-8, Doshomachi 2-chome, Chuo-ku, Osaka-shi, Osaka 541-0045, Japan

    Published in Swissreg on 08.06.2022

  4. 19-05-2016

    Transferì

    Owner
    International Institute of Cancer Immunology, Inc., 13-9, Enoki-cho, Suita-shi, Osaka-fu, Japan, CHUGAI SEIYAKU KABUSHIKI KAISHA, 5-1, Ukima 5-chome,, Kita-ku, Tokyo, 115-8543, Japan, Sumitomo Dainippon Pharma Co., Ltd., 6-8, Dosho-machi 2-chome, Chuo-ku, Osaka-shi, Osaka 541-8524, Japan → International Institute of Cancer Immunology, Inc., 13-9, Enoki-cho, Suita-shi, Osaka-fu, Japan, Sumitomo Dainippon Pharma Co., Ltd., 6-8, Dosho-machi 2-chome, Chuo-ku, Osaka-shi, Osaka 541-8524, Japan

    Published in Swissreg on 19.05.2016

  5. 23-09-2014

    Adressa midada

    Owner
    International Institute of Cancer Immunology, Inc., 13-9, Enoki-cho, Suita-shi, Osaka-fu, Japan, CHUGAI SEIYAKU KABUSHIKI KAISHA, 5-1, Ukima 5-chome,, Kita-ku, Tokyo, 115-8543, Japan, Dainippon Sumitomo Pharma Co., Ltd., 6-8, Dosho-machi 2-chome, Chuo-ku, Osaka-shi, Osaka-fu, Japan → International Institute of Cancer Immunology, Inc., 13-9, Enoki-cho, Suita-shi, Osaka-fu, Japan, CHUGAI SEIYAKU KABUSHIKI KAISHA, 5-1, Ukima 5-chome,, Kita-ku, Tokyo, 115-8543, Japan, Sumitomo Dainippon Pharma Co., Ltd., 6-8, Dosho-machi 2-chome, Chuo-ku, Osaka-shi, Osaka 541-8524, Japan

    Published in Swissreg on 23.09.2014

  6. 16-07-2014

    Adressa midada

    Representative
    BOHEST AG, Postfach 160, 4003 Basel → BOHEST AG, Holbeinstrasse 36-38, 4051 Basel

    Published in Swissreg on 16.07.2014

  7. 16-10-2009

    Represchentant inscrit

    Representative
    BOHEST AG, Postfach 160, 4003 Basel

    Published in Swissreg on 16.10.2009

  8. 07-10-2009

    Concedì

    Published in Swissreg on 07.10.2009

Partidas

Possessur

International Institute of Cancer Immunology, Inc.

13-9, Enoki-cho, Suita-shi, Osaka-fu, JP

Sumitomo Pharma Co., Ltd.

6-8, Doshomachi 2-chome Chuo-ku Osaka-shi, Osaka 541-0045, JP

Represchentant

BOHEST AG

Holbeinstrasse 36-38, 4051 Basel

Inventur

TAKASU, Hideo

Nishinomiya-shi, Hyogo 6620084, JP

SAMIZO, Fumio

Suita-shi, Osaka 5650854, JP

SUGIYAMA, Haruo

Minoo-shi, Osaka 5620036, JP

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.